NUGL EV / EBITDA
Mi az NUGL EV / EBITDA?
A EV / EBITDA az NUGL, Inc. - N/A
Mi a EV / EBITDA meghatározása?
Az EV / EBITDA a vállalati érték a kamat, az adózás, az értékcsökkenés és az amortizáció előtti eredményekkel elosztva. Ez azt jelenti, hogy mennyire drága egy állomány, és gyakrabban érvényesül a vállalatok közötti összehasonlításnál, mint az ár / nyereség arány. Megméri az árat (vállalati érték formájában), amelyet a befektető fizet a vállalat pénzforgalmának javára (EBITDA formájában).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA a Technology szektor a OTC-on cégekben a NUGL -hoz képest
Mit csinál NUGL?
NUGL Inc. operates as a vertically integrated medical cannabis company. It operates cultivation facility, processing facility, three retail dispensaries, conditional licenses, and supplies and exports medical cannabis primarily in the Caribbean, Australia, and South America. The company was founded in 2018 and is based in Kingston, Jamaica.
ev / ebitda -hoz hasonló cégek NUGL
- Sino Vision Worldwide nak EV / EBITDA N/A van
- Respiri nak EV / EBITDA N/A van
- Fuse Cobalt Inc nak EV / EBITDA N/A van
- CCT Fortis nak EV / EBITDA N/A van
- XPhyto Therapeutics nak EV / EBITDA N/A van
- Vital Mobile nak EV / EBITDA N/A van
- NUGL nak EV / EBITDA N/A van
- Australian Bauxite nak EV / EBITDA N/A van
- Evershine nak EV / EBITDA N/A van
- StrikeForce Technologies nak EV / EBITDA N/A van
- Arcutis Biotherapeutics Inc nak EV / EBITDA N/A van
- Golden Dawn Minerals nak EV / EBITDA N/A van
- Austral Gold nak EV / EBITDA N/A van